Literature DB >> 18396508

Augmentation strategies in the treatment of major depressive disorder. Recent findings and current status of augmentation strategies.

J Craig Nelson1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 18396508     DOI： 10.1017/s1092852900016011

Source DB:  PubMed          Journal:  CNS Spectr        ISSN： 1092-8529            Impact factor:   3.790


× No keyword cloud information.
  10 in total

1.  Fluoxetine potentiation of methylphenidate-induced neuropeptide expression in the striatum occurs selectively in direct pathway (striatonigral) neurons.

Authors:  Vincent Van Waes; Betsy Carr; Joel A Beverley; Heinz Steiner
Journal:  J Neurochem       Date:  2012-07-23       Impact factor: 5.372

2.  Potentiated gene regulation by methylphenidate plus fluoxetine treatment: Long-term gene blunting (Zif268, Homer1a) and behavioral correlates.

Authors:  Joel A Beverley; Cassandra Piekarski; Vincent Van Waes; Heinz Steiner
Journal:  Basal Ganglia       Date:  2014-12-01

3.  Selective serotonin reuptake inhibitor antidepressants potentiate methylphenidate (Ritalin)-induced gene regulation in the adolescent striatum.

Authors:  Vincent Van Waes; Joel Beverley; Michela Marinelli; Heinz Steiner
Journal:  Eur J Neurosci       Date:  2010-08       Impact factor: 3.386

4.  The 5-HT1B serotonin receptor regulates methylphenidate-induced gene expression in the striatum: Differential effects on immediate-early genes.

Authors:  David Alter; Joel A Beverley; Ronak Patel; Carlos A Bolaños-Guzmán; Heinz Steiner
Journal:  J Psychopharmacol       Date:  2017-07-18       Impact factor: 4.153

Review 5.  Life-long consequences of juvenile exposure to psychotropic drugs on brain and behavior.

Authors:  Heinz Steiner; Brandon L Warren; Vincent Van Waes; Carlos A Bolaños-Guzmán
Journal:  Prog Brain Res       Date:  2014       Impact factor: 2.453

6.  Fluoxetine potentiation of methylphenidate-induced gene regulation in striatal output pathways: potential role for 5-HT1B receptor.

Authors:  Vincent Van Waes; Sarah Ehrlich; Joel A Beverley; Heinz Steiner
Journal:  Neuropharmacology       Date:  2014-09-16       Impact factor: 5.250

7.  Selective serotonin re-uptake inhibitors potentiate gene blunting induced by repeated methylphenidate treatment: Zif268 versus Homer1a.

Authors:  Vincent Van Waes; Malcolm Vandrevala; Joel Beverley; Heinz Steiner
Journal:  Addict Biol       Date:  2013-06-13       Impact factor: 4.280

Review 8.  Addiction-related gene regulation: risks of exposure to cognitive enhancers vs. other psychostimulants.

Authors:  Heinz Steiner; Vincent Van Waes
Journal:  Prog Neurobiol       Date:  2012-10-17       Impact factor: 11.685

9.  Fluoxetine Potentiates Oral Methylphenidate-Induced Gene Regulation in the Rat Striatum.

Authors:  Connor Moon; Matt Marion; Panayotis K Thanos; Heinz Steiner
Journal:  Mol Neurobiol       Date:  2021-07-02       Impact factor: 5.682

10.  Efficacy of adjunctive aripiprazole in patients with major depressive disorder whose symptoms worsened with antidepressant monotherapy.

Authors:  J Craig Nelson; Zia Rahman; Kimberly K Laubmeier; James M Eudicone; Robert D McQuade; Robert M Berman; Ronald N Marcus; Ross A Baker; John J Sheehan
Journal:  CNS Spectr       Date:  2014-03-18       Impact factor: 3.790
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.